AI-powered protein dynamics research advancing drug discovery at MIT and ASU
| | |

AI-Designed Drugs Are Entering Human Trials: Inside the Quiet Pharmaceutical Revolution of 2026

ByThe Healthcare Discovery Team

For the first time in pharmaceutical history, molecules designed almost entirely by artificial intelligence are surviving Phase 2 trials in real patients. From Insilico’s rentosertib to Isomorphic Labs’ multi-billion dollar…

Foundation model AI converging with computational drug discovery and protein design after a major biotech acquisition
| | |

Anthropic Just Bought a Drug Discovery Startup for $400M. Here Is What It Means for Healthcare AI.

ByThe Healthcare Discovery Team

A foundation model company just paid $400 million in stock for a team of fewer than 10 people. The implications for drug discovery, precision medicine, and the entire healthcare AI…

David Fajgenbaum of Every Cure, the nonprofit focused on AI-powered drug repurposing
| | |

The Cure Hiding in Plain Sight: How Every Cure Is Rewriting the Rules of Drug Discovery

ByThe Healthcare Discovery Team

Every Cure is a nonprofit using AI and drug repurposing to uncover treatments hidden inside existing medicines. Founded by physician-scientist David Fajgenbaum after a repurposed drug saved his own life,…

Dynamic protein ribbons shifting through conformations as AI maps motion for drug discovery
| | |

MIT, ASU, and the New Frontier of Protein Motion: Why Drug Discovery Is Moving Beyond Static Structure

ByThe Healthcare Discovery Team

Two university-led advances point to the next chapter in AI-enabled drug discovery. MIT’s VibeGen designs proteins by their motion profiles. ASU’s fast sampling method accelerates access to conformational landscapes. Together,…